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will include a minimum of 2600 users worldwide. CONCLU-
SION: BeautyQol is the ﬁrst and, to date, the only user centered
instrument speciﬁc in cosmetology that is being developed simul-
taneously in 13 countries. BeautyQol is going to be a very valu-
able tool for national and international assessment of various
cosmetic strategies.
PSS34
QUALITY OF LIFE IN PATIENTSWITHVITILIGO. USE OF
SINGLE ITEM ANALYSIS
Sampogna F1,Tabolli S2, Raskovic D1, Guerra L1,Abeni D1
1IDI IRCCS, Rome, Italy, 2IDI IRCCS, ROME, Italy
Quality of life (QoL) in patients with dermatological conditions
is evaluated using generic and speciﬁc instruments. Even though
these instruments are created to give as a result one or more
total scores, the analysis of the answers to the single items may
give important information on QoL impairment of patients.
OBJECTIVES: To investigate the QoL of patients with vitiligo,
also analyzing single questions from a QoL instrument.
METHODS: Single items from the Skindex-29 questionnaire, a
QoL dermatology-speciﬁc instrument, were analyzed in 181
patients with vitiligo. Answers to the Skindex-29 items were
given on a 5-point scale, from “never” to “all the time”.
RESULTS: The QoL problems more frequently experienced
often or all the time were: worry of the disease getting worse
(60%) or being a serious condition (40%), anger (37%), embar-
rassment (34%), depression (31%), affect on having social life
affected (28%), and shame (28%). The association of QoL
impairment with the probable presence of depression or anxiety,
evaluated using the 12-item General Health Questionnaire
(GHQ-12), was very strong for all the items, and remained
signiﬁcant also when taking into account simultaneously gender,
age, clinical severity, family history, and localization of vitiligo.
CONCLUSION: The answers to single items from a
dermatology-speciﬁc quality of life questionnaire may provide
clinicians with relevant additional information on the physical
and mental health status of patients.
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THE IMPACT OF GLAUCOMA ON QUALITY OF LIFE:
COMPARISONWITHTHE CHRONIC DISEASES
OSTEOPOROSIS,TYPE 2 DIABETES MELLITUS,
AND DEMENTIA
Walt JG1, Mills T2, Hansen JE1
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OBJECTIVE: Chronic diseases have a long-term negative impact
on quality of life (QoL). Few studies have investigated the impact
of glaucoma on patients’ QoL in comparison to other chronic
diseases observed in patients with similar demographics. We
performed a systematic literature search to assess QoL in glau-
coma, osteoporosis, type 2 diabetes mellitus, and dementia.
METHODS: We searched MEDLINE, BIOSIS, EMBASE, and
Cochrane databases. RESULTS: A total of 146 QoL publications
were identiﬁed (some reported >1 instrument): Short-Form
Health Survey [SF]-36 was used in 77 (glaucoma = 8; osteoporo-
sis = 25; diabetes = 40; dementia = 4), SF-12 in 19 (glau-
coma = 1, osteoporosis = 5, diabetes = 9, dementia = 4), SF-20
in 7 (glaucoma = 1, diabetes = 6), EuroQol EQ-5D in 29 (glau-
coma = 2; osteoporosis = 9; diabetes = 9; dementia = 9), Sickness
Impact Proﬁle (SIP) in 6 (glaucoma = 2; osteoporosis = 1; diabe-
tes = 3, dementia = 0), and Health Utilities Index-Mark III
(HUI-III) in 17 (glaucoma + diabetes = 1; diabetes only = 11;
osteoporosis = 3; dementia = 2). Similar trends were observed
across studies using SF-36, -12 or -20: social functioning
domains were affected least, and physical domains affected most
in glaucoma. In general, QoL was affected to a similar degree in
all diseases. By EQ-5D, in glaucoma, utility decreased with
increasing glaucomatous damage. The highest mean values using
EQ-5D were similar across all four diseases; mean overall utility
scores were generally slightly lower (QoL impacted more) in
osteoporosis, diabetes and dementia than glaucoma. Mean SIP
scores increased (QoL decreased) with increasing severity of
glaucoma. Total SIP scores for glaucoma were similar to those for
diabetes. By HUI-III, QoL impact also was similar in glaucoma
and diabetes. CONCLUSION: QoL in glaucoma decreases with
increasing disease severity; physical domains are affected more
than social domains. Although there are limited published QoL
studies in glaucoma, its impact on QoL appears to be broadly
consistent with other serious chronic diseases. Further efforts
towards diagnosing and treating glaucoma, to reduce ﬁnancial
burden on health care systems and society, are warranted.
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COMPARISON OFTHE QUALITY OF LIFE IMPACT OF
PERIPHERALVISION LOSSVERSUS CENTRALVISION LOSS
Walt JG1, Evans K2, Hansen JE1
1Allergan Inc, Irvine, CA, USA, 2Wolters Kluwer Health, Chester, UK
OBJECTIVE: Vision disorders have a negative impact on quality
of life (QoL). While the impairment of QoL in central-vision loss
(CVL) disorders, e.g. age-related macular degeneration (ARMD),
is widely acknowledged, the QoL impact of peripheral-vision
loss (PVL) disorders, e.g. glaucoma, is less well-known. We per-
formed a systematic literature search to assess the effect on
QoL of PVL versus CVL. METHODS: We searched MEDLINE,
BIOSIS, EMBASE, and Cochrane databases. RESULTS: A total
of 87 publications were identiﬁed (some reported >1 instrument):
Short-Form Health Survey (SF)-36 was used in 23 (PVL = 2;
CVL = 21), SF-12 in 6 (PVL = 1; CVL = 5), National Eye Insti-
tute Visual Function Questionnaire (NEI-VFQ)-51 in 11
(PVL = 4; CVL = 7), NEI-VFQ-39 in 9 (PVL = 1; CVL = 8), NEI-
VFQ-25 in 36 (PVL = 11; CVL = 25), EuroQol EQ-5D in 3
(PVL = 1; CVL = 2), Visual Function-14 (VF-14) in 20 (PVL = 1;
CVL = 19), Sickness Impact Proﬁle (SIP) in 4 (PVL = 2 [1 study];
CVL = 2), and Impact of Vision Impairment (IVI) in 1 (including
3 diseases: glaucoma, retinopathy [PVL] and ARMD [CVL]). By
SF-36, vitality was impacted most in PVL. By SF-36 and SF-12,
generally, mental health domains were affected more in PVL than
CVL; physical domains were affected most in CVL. Mental
aspects of QoL were affected more in PVL than CVL in all
NEI-VFQ studies; ARMD and glaucoma impacted different
domains. QoL was generally lower in glaucoma than ARMD,
although results varied amongst studies. By EQ-5D, QoL in
PVL and CVL were similarly affected. By VF-14 and SIP, CVL
impacted QoL slightly more than PVL. By SIP, psychosocial and
physical domains were affected equally in PVL. In the IVI study,
PVL affected QoL slightly more than CVL (except glaucoma on
the social scale). CONCLUSION: Results showed in general,
PVL and CVL disorders have a signiﬁcant impact on QoL. More
QoL research towards better understanding patients’ concerns
with their PVL and CVL disorders are warranted.
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MAPPINGTHE DERMATOLOGY QUALITY OF LIFE INDEX
(DLQI) TO HEALTH-RELATED UTILITYVIATHE SF-12 IN
SUBJECTSWITH ECZEMA
Currie CJ1, Sidhu M2, Poole CD3
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OBJECTIVE: The purpose of this study was to conduct a statis-
tical mapping between patient reported disease-speciﬁc quality of
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life in atopic dermatitis (AD) and a generic quality of life measure
and from this use optimised algorithms to estimate health utility.
METHODS: Multinomial logistic regression was used to esti-
mate response probabilities to the SF-12 health survey from
responses to the Dermatology Life Quality Index (DLQI) in
patients enrolled into a clinical trial studying the long-term use
of tacrolimus ointment. A random sample of 70% of patient
responses was used for the regression analysis, with the remain-
ing 30% used to test the predictive ability of the response
mapping. Predicted and actual SF-12 responses were converted
to SF-6D and EQ-5D health utilities using published algorithms
(Brazier 2004 and Gray 2006) by Monte Carlo simulation.
RESULTS: Evaluable data were available for 255 patients, 40%
of whom were male, and for which the median age at screening
was 28 years (IQR 22 to 38). The percentage of variance in item
response attributable to predictor variable change ranged 15.6%
(SFCALM) to 33.3% (SFLESS). The mean predicted utility in the
test dataset was 0.797 (sd 0.092) by the SF-6D method and 0.787
(0.210) by EQ-5D. The mean squared error (MSE) between the
actual and predicted utilities were 0.013 for SF-6D and 0.068 for
EQ-5D. Predicted SF-6D utility was within 10% of the actual
utility in 62.7% of cases while for predicted EQ-5D utility this
fell to 39.8%. CONCLUSION: Response mapping of disease-
speciﬁc quality of life in AD to generic quality of life SF-12
produced more reliable estimates of SF-6D utility than EQ-5D
utility, and correlated closely with similar estimates made from a
standard assessment of disease severity in eczema.
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PATIENTS’ PERCEPTION OF LIFE FREE OF GLASSES AFTER
CATARACT SURGERY: DEVELOPMENT OFTHE FREEDOM
FROM GLASSESVALUE SCALE (FGVS©)
Arnould B1, Benmedjahed K1, Berdeaux G2, Gil-Campos I3,
Vigneux M4, Guillemin I1
1Mapi Values France, Lyon, France, 2Alcon France, Rueil-Malmaison,
France, 3Mapi Research Institute, Lyon, France, 4Mapi Values, Lyon,
France
OBJECTIVE: To develop a patient self-administered question-
naire assessing the added value of complete independence from
glasses in patients after multifocal intraocular lens surgery.
METHODS: A qualitative study was performed to develop the
questionnaire. Exploratory interviews with ﬁve cataract patients
and six presbyopia patients with ReSTOR® implanted in both
eyes for at least 6 months were conducted. After interview analy-
sis, a conceptual model was developed. Items were generated
simultaneously in French and Spanish based on the identiﬁed
concepts and using patients’ own words. Six patients completed
the French test questionnaire and provided comments regarding
questionnaire’s structure and content. The questionnaire was
reﬁned. The Spanish test questionnaire then underwent a clini-
cian review and was tested with four patients. Test versions were
reﬁned and the French and Spanish pilot versions of the ques-
tionnaire were subsequently produced. RESULTS: Nine global
concepts were included in the conceptual model: global vision,
practical constraints related to wearing glasses, impact of eye
surgery on patient’s life, improvement of the practical issues
without glasses, improvement of the psychological constraints
without glasses, physical appearance / aesthetic aspect (self-
image and in the eyes of the others), surgery left behind, recom-
mendation of surgery to others. The ﬁrst version of the test
questionnaire contained 26 items. After the test with French
patients, two items were deleted. The Spanish test questionnaire
was modiﬁed accordingly. Minor additional changes were
brought after clinician review and patient tests of the Spanish
version. The ﬁnal questionnaire named ‘Freedom from Glasses
Value Scale (FGVS©)’ contained 21 items and four general addi-
tional questions. CONCLUSION: Beyond functional aspects,
this qualitative study identiﬁed additional beneﬁts in cataract
and presbyopic patients’ living free of glasses after receiving
ReSTOR®. The FGVS© will allow these beneﬁts to be assessed.
It is available in French and Spanish. UK English and Danish
linguistically validated versions are also available.
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ESTIMATING HEALTH RELATED UTILITY FROM SYMPTOM
SEVERITY IN ATOPIC DERMATITIS (ECZEMA)
Poole CD1, Sidhu M2, Currie CJ3
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OBJECTIVE: The purpose of this study was to conduct a
statistical mapping between standard assessments of disease
severity in atopic dermatitis (AD) and a generic quality of life
measure and use optimised algorithms to estimate health utility.
METHODS: Multinomial logistic regression was used to esti-
mate response probabilities to the SF-12 health survey from
assessment of AD severity using the modiﬁed Eczema Area &
Severity Index (mEASI) in patients enrolled into a clinical trial
studying the long-term use of tacrolimus ointment. A random
sample of 70% of patient responses was used for the regression
analysis, with the remaining 30% used to test the predictive
ability of the response mapping. Predicted and actual SF-12
responses were converted to SF-6D and EQ-5D health utilities
using published algorithms (Brazier 2004 and Gray 2006) by
Monte Carlo simulation. RESULTS: Evaluable data were avail-
able for 255 patients, 40% of whom were male, and for which
the median age at screening was 28 years (IQR 22 to 38). The
percentage of variance in item response attributable to predictor
variable change ranged from 19.8% (SFCALM) to 37.5%
(SFENER). The mean predicted utility in the test dataset was
0.799 (sd 0.083) by the SF-6D method and 0.778 (0.203) by
EQ-5D. The mean squared error (MSE) between the actual and
predicted utilities were 0.012 for SF-6D and 0.075 for EQ-5D.
Predicted SF-6D utility was within 10% of the actual utility in
64.8% of cases while for predicted EQ-5D utility this fell to
39.9%. CONCLUSION: In this study response mapping of AD
symptom severity to SF-12 produced more reliable estimates of
SF-6D utility than EQ-5D utility. In young adults with low
co-morbidity the sensitivity of SF-6D at higher utilities make it
be a more appropriate choice than EQ-5D where cases would
otherwise be classiﬁed in perfect health.
PSS40
QUALITY OF LIFE AND PSYCHOLOGICAL PROBLEMS IN
PATIENTSWITH ORAL MUCOSAL DISEASES
Tabolli S1, Di Pietro C2, Sampogna F2,Abeni D2
1IDI IRCCS, ROME, Italy, 2IDI IRCCS, Rome, Italy
OBJECTIVE: The measurement of oral health related QoL
(OHRQoL) is generally limited to dental diseases. Our objective
was to evaluate patients with oral mucosal diseases using an oral
health-speciﬁc questionnaire (OHIP-14), a generic health status
questionnaire (SF-12) and a general psychological health ques-
tionnaire (GHQ-12) to identify the possible presence of condi-
tions such as depression or anxiety. METHODS: Consecutive
patients coming to the oral health care unit of IDI-IRCCS in
Rome were asked to complete the OHIP-14, the SF-12, and the
GHQ-12 questionnaires. Both physicians and patients gave a
global assessment of severity of disease (PhGA and PtGA, respec-
tively) on a 5-point scale. Agreement between physiscians and
patients was assessed using Cohen’s K statistic. RESULTS: Of
218 patients contacted, 206 participated in the study. Oral ulcer-
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